These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27485424)

  • 1. Development of a New De Novo Design Algorithm for Exploring Chemical Space.
    Mishima K; Kaneko H; Funatsu K
    Mol Inform; 2014 Dec; 33(11-12):779-89. PubMed ID: 27485424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical-Space-Based de Novo Design Method To Generate Drug-Like Molecules.
    Takeda S; Kaneko H; Funatsu K
    J Chem Inf Model; 2016 Oct; 56(10):1885-1893. PubMed ID: 27632418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
    Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
    Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AutoDesigner, a
    Bos PH; Houang EM; Ranalli F; Leffler AE; Boyles NA; Eyrich VA; Luria Y; Katz D; Tang H; Abel R; Bhat S
    J Chem Inf Model; 2022 Apr; 62(8):1905-1915. PubMed ID: 35417149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo drug design using multiobjective evolutionary graphs.
    Nicolaou CA; Apostolakis J; Pattichis CS
    J Chem Inf Model; 2009 Feb; 49(2):295-307. PubMed ID: 19434831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha sphere filter method: Application of pseudomolecular descriptors in virtual screening of 2D chemical structures.
    Muta H; Hirayama N
    J Comput Chem; 2010 Aug; 31(11):2225-32. PubMed ID: 20340104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evolutionary algorithm for de novo optimization of functional transition metal compounds.
    Chu Y; Heyndrickx W; Occhipinti G; Jensen VR; Alsberg BK
    J Am Chem Soc; 2012 May; 134(21):8885-95. PubMed ID: 22524432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.
    Caballero J; Alzate-Morales JH; Vergara-Jaque A
    J Chem Inf Model; 2011 Nov; 51(11):2920-31. PubMed ID: 22011048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in de novo design strategy for practical lead identification.
    Honma T
    Med Res Rev; 2003 Sep; 23(5):606-32. PubMed ID: 12789688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor flexibility in de novo ligand design and docking.
    Alberts IL; Todorov NP; Dean PM
    J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational approaches for drug discovery.
    Hung CL; Chen CC
    Drug Dev Res; 2014 Sep; 75(6):412-8. PubMed ID: 25195585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites.
    Laurie AT; Jackson RM
    Bioinformatics; 2005 May; 21(9):1908-16. PubMed ID: 15701681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
    Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
    ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus-2D: a new approach to the design of targeted combinatorial chemical libraries.
    Cho SJ; Zheng W; Tropsha A
    Pac Symp Biocomput; 1998; ():305-16. PubMed ID: 9697191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition.
    Chakraborty S; Ramachandran B; Basu S
    Mol Biosyst; 2014 Oct; 10(10):2684-92. PubMed ID: 25088750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic clustering of docking poses in virtual screening process using self-organizing map.
    Bouvier G; Evrard-Todeschi N; Girault JP; Bertho G
    Bioinformatics; 2010 Jan; 26(1):53-60. PubMed ID: 19910307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.